Clal Biotechnology Industries Ltd. (TLV: CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA35.60
+0.50 (1.42%)
Nov 18, 2024, 5:24 PM IDT
CBI Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.03 | 0.1 | 0.37 | 0.22 | 0.21 | 113.29 | Upgrade
|
| Revenue Growth (YoY) | -91.14% | -71.89% | 65.18% | 8.74% | -99.82% | 787.39% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 57.9 | Upgrade
|
| Gross Profit | 0.03 | 0.1 | 0.37 | 0.22 | 0.21 | 55.39 | Upgrade
|
| Selling, General & Admin | 7.63 | 9.76 | 12.27 | 12.22 | 10.3 | 47.76 | Upgrade
|
| Research & Development | - | - | - | - | - | 20.07 | Upgrade
|
| Operating Expenses | 8.16 | 10.29 | 12.88 | 12.87 | 10.85 | 67.83 | Upgrade
|
| Operating Income | -8.13 | -10.18 | -12.51 | -12.65 | -10.64 | -12.44 | Upgrade
|
| Interest Expense | -3.76 | -3.54 | -3.73 | -1.76 | - | -15.13 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.13 | 0.01 | - | - | 1.48 | Upgrade
|
| Earnings From Equity Investments | -27.8 | -17 | -22.39 | -30.81 | -28.94 | -71.42 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.36 | 0.36 | 4.23 | -1.61 | -1.44 | 4.65 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.06 | -0.86 | -2.31 | 11.38 | 103.03 | 1.61 | Upgrade
|
| EBT Excluding Unusual Items | -40.3 | -31.09 | -36.69 | -35.44 | 62.02 | -91.25 | Upgrade
|
| Gain (Loss) on Sale of Investments | -31.61 | 3 | -8.03 | -31.15 | 42.72 | 7.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 22.37 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -278.68 | Upgrade
|
| Legal Settlements | - | - | - | - | - | 4.94 | Upgrade
|
| Other Unusual Items | - | - | 3.7 | - | - | - | Upgrade
|
| Pretax Income | -71.9 | -28.09 | -41.02 | -66.59 | 127.11 | -357.94 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -31.73 | Upgrade
|
| Earnings From Continuing Operations | -71.9 | -28.09 | -41.02 | -66.59 | 127.11 | -326.22 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -54.41 | -61.63 | -77.27 | - | Upgrade
|
| Net Income to Company | -71.9 | -28.09 | -95.43 | -128.21 | 49.84 | -326.22 | Upgrade
|
| Minority Interest in Earnings | -2.83 | -2.96 | 33.69 | 38.63 | 59.19 | 172.11 | Upgrade
|
| Net Income | -74.74 | -31.05 | -61.74 | -89.58 | 109.03 | -154.11 | Upgrade
|
| Net Income to Common | -74.74 | -31.05 | -61.74 | -89.58 | 109.03 | -154.11 | Upgrade
|
| Shares Outstanding (Basic) | 176 | 157 | 157 | 158 | 161 | 161 | Upgrade
|
| Shares Outstanding (Diluted) | 176 | 157 | 157 | 158 | 161 | 161 | Upgrade
|
| Shares Change (YoY) | 24.92% | - | -1.01% | -1.74% | 0.01% | 1.70% | Upgrade
|
| EPS (Basic) | -0.43 | -0.20 | -0.39 | -0.57 | 0.68 | -0.96 | Upgrade
|
| EPS (Diluted) | -0.43 | -0.20 | -0.39 | -0.57 | 0.68 | -0.96 | Upgrade
|
| Free Cash Flow | -8.05 | -8.52 | -60.31 | -42.92 | -36.41 | 24.2 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.38 | -0.27 | -0.23 | 0.15 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.220 | - | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 48.89% | Upgrade
|
| Operating Margin | -25396.88% | -9789.42% | -3380.00% | -5645.09% | -5166.02% | -10.98% | Upgrade
|
| Profit Margin | -233553.13% | -29856.73% | -16686.49% | -39992.41% | 52925.73% | -136.03% | Upgrade
|
| Free Cash Flow Margin | -25159.38% | -8190.38% | -16300.00% | -19160.71% | -17675.24% | 21.36% | Upgrade
|
| EBITDA | -8.06 | -10.03 | 4.6 | 9.87 | 13.23 | 8.58 | Upgrade
|
| EBITDA Margin | - | - | 1242.70% | 4404.46% | 6420.39% | 7.58% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.15 | 17.1 | 22.51 | 23.87 | 21.02 | Upgrade
|
| EBIT | -8.13 | -10.18 | -12.51 | -12.65 | -10.64 | -12.44 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -10.98% | Upgrade
|
| Revenue as Reported | 1.98 | 39.73 | 18.03 | 55.26 | 168.58 | 158.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.